Junichiro Watanabe

19PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersRadiation therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

|Mar 26, 2026
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study.

Akihiko Shimomura, Takahiro Kogawa, Koji Matsumoto

|Mar 13, 2026
Clinical Outcomes and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A Real-World Data Analysis.

Moe Itakura, Yoshiya Horimoto, Yumiko Ushiyama

|Jan 31, 2026
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study.

Yuri Takamatsu, Yoshiya Horimoto, Yasuo Miyoshi

|Jul 20, 2025
Breast tumors with intermediate ER expression differ biologically from ER-low tumors and exhibit a more favorable prognosis.

Yuko Ueki, Yoshiya Horimoto, Kazuharu Harada

|Jan 22, 2024
Efficacy of radiation therapy in Japanese patients with positive margins after breast-conserving surgery.

Toshitaka Uomori, Yoshiya Horimoto, Yuko Ueki

Pageof 4

Frequent Collaborators

9 joint publications

Yoshiya Horimoto

3 joint publications

Shogo Nakamoto

3 joint publications

Yumiko Ishizuka

2 joint publications

Takashi Ishikawa